Get key insights from Beta Bionics’ Q3 2025 earnings: record growth, raised revenue guidance, strong iLet adoption, and innovation pipeline.

On one wall of endocrinologist Kevan Herold’s office hangs artwork by a girl who joined one of his type 1 diabetes trials when she was 11 years old. The girl was diagnosed with stage 2 of the disease, ...

Optimal blood sugar management relies on foods rich in Fiber, Protein, and Healthy Fats, which slow glucose entry into the ...

A recent study identified that a special group of pancreatic beta cells are crucial for triggering the blood sugar response. We know that beta cells of the pancreas play an important role in ...

Researchers demonstrated that pancreatic β cells from type 2 diabetes donors can partially regain glucose responsiveness when ...

IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...

Overview of peripheral and central insulin actions (black arrows). The vast majority of insulin hormones are synthesized by the pancreas. Insulin crosses the blood‒brain barrier (BBB) to act within ...

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated ...

Beta-blockers can cause either low blood sugar (hypoglycemia) or high blood sugar (hyperglycemia). They can also mask the symptoms of low blood sugar, meaning that a person may not be aware they have ...